The Distinct Role of Family History and Polygenic Risk Scores of Psychiatric Disorders on Lithium Response in Bipolar Disorder
Bipolar Disorders · 2026-06 · 28 (4)
DOI: 10.1111/bdi.70126 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bipolar Disorders, online erschienen am 09.06.2026. Verfasst von Mete Ercis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA. Hauptthemen laut MEDLINE: Bipolar Disorder, Lithium Compounds, Antimanic Agents, Multifactorial Inheritance. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: Thomas and Elizabeth Grainger Fund in Bipolar Functional Genomics and Drug Development, Marriott Foundation, Center for Individualized Medicine, Mayo Clinic.
Abstract (Originalsprache)
Background
This study aimed to explore the effect of family history (FH) and polygenic risk scores (PRS) for multiple psychiatric disorders on lithium response in bipolar disorder (BD).
Method
The sample included patients from the Mayo Clinic BD Biobank. FH in first‐degree relatives was obtained via the patient questionnaire. Linear regression models tested the association of FH and PRS for BD, major depressive disorder (MDD), schizophrenia (SCZ), alcohol use disorder (AUD), anxiety disorder (ANX), and attention‐deficit/hyperactivity disorder (ADHD) with lithium response measured by the Alda A score adjusted for the Alda B sum score. Post hoc models additionally adjusted for clinical covariates (age at onset, rapid cycling, and BD subtype).
Results
716 patients had Alda scores for lithium response (61.9% females, mean age = 43.4 years). FH‐BD ( β = −0.57, p = 0.015), AUD ( β = −0.44, p = 0.045), and ANX ( β = −0.61, p = 0.050) were associated with worse lithium response. After adjusting for clinical covariates, associations for FH‐BD and FH‐ANX were no longer significant. PRS‐BD was associated with better response ( β = 0.22, p = 0.041), while PRS‐MDD ( β = −0.28, p = 0.01) and PRS‐ADHD ( β = −0.24, p = 0.028) were associated with worse response, with effects largely unchanged after adjusting for clinical covariates. In the combined model considering all FHs simultaneously, only FH‐BD remained significantly associated with worse lithium response ( β = −0.71, p = 0.039). In the combined model for PRS, only PRS‐BD ( β = 0.31, p = 0.008; better response) and PRS‐MDD ( β = −0.29, p = 0.020; worse response) showed significant associations.
Conclusions
In this exploratory study, FH‐BD, AUD, and ANX were associated with poor response, though only FH‐AUD remained significant after adjusting for clinical factors. PRS‐BD predicted better response, while PRS‐MDD was associated with worse response. These findings suggest independent and potentially complementary roles of FH and PRS. Integrating both familial and genetic risk measures may improve personalized treatment strategies and outcomes for BD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.
- Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA.
- Lindner Center of HOPE Research Institute, Mason, Ohio, USA.
- Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
- Department of Psychiatry and Behavioral Sciences, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
- Department of Psychiatry & Behavioral Sciences, Johns Hopkins University, Baltimore, Maryland, USA.
ORCID-Profile: Mete Ercis, Lindsay M Melhuish Beaupre, Francisco Romo-Nava, Alfredo B Cuellar-Barboza, Miguel L Prieto, Mark A Frye, Joanna M Biernacka, Balwinder Singh
Förderung
- Thomas and Elizabeth Grainger Fund in Bipolar Functional Genomics and Drug Development
- Marriott Foundation
- Center for Individualized Medicine, Mayo Clinic
- J. Willard and Alice S. Marriott Foundation
Zitieren
APA
Ercis, M., Coombes, B. J., Melhuish Beaupre, L. M., Solares-Bravo, M., Veldic, M., Moore, K. M., Betcher, H. K., Romo-Nava, F., Ozerdem, A., Bond, D. J., Cuellar-Barboza, A. B., Prieto, M. L., McElroy, S. L., Frye, M. A., Biernacka, J. M., & Singh, B. (2026). The Distinct Role of Family History and Polygenic Risk Scores of Psychiatric Disorders on Lithium Response in Bipolar Disorder. Bipolar Disorders, 28(4). https://doi.org/10.1111/bdi.70126
Vancouver
Ercis M, Coombes BJ, Melhuish Beaupre LM, Solares-Bravo M, Veldic M, Moore KM, et al. The Distinct Role of Family History and Polygenic Risk Scores of Psychiatric Disorders on Lithium Response in Bipolar Disorder. Bipolar Disorders. 2026;28(4). doi:10.1111/bdi.70126
BibTeX
@article{Ercis2026,
author = {Ercis, Mete and Coombes, Brandon J and Melhuish Beaupre, Lindsay M and Solares-Bravo, Melissa and Veldic, Marin and Moore, Katherine M and Betcher, Hannah K and Romo-Nava, Francisco and Ozerdem, Aysegul and Bond, David J and Cuellar-Barboza, Alfredo B and Prieto, Miguel L and McElroy, Susan L and Frye, Mark A and Biernacka, Joanna M and Singh, Balwinder},
title = {The Distinct Role of Family History and Polygenic Risk Scores of Psychiatric Disorders on Lithium Response in Bipolar Disorder},
journal = {Bipolar Disorders},
year = {2026},
volume = {28},
number = {4},
doi = {10.1111/bdi.70126}
}
EUVIMED